Pamela Yanchik Connealy
Independent DirectorMs. Pamela Yanchik Connealy, also known as Pam, M.B.A. is Independent Director of Orchestra BioMed Holdings, Inc. since January 2023. She served as an Independent Director at Health Sciences Acquisitions Corporation 2 (formerly known as Orchestra BioMed, Inc.) since February 2020. She was Chief Financial Officer at Pyxis Oncology, Inc since July 19, 2021 until July 1, 2025 and also was its Chief Operating Officer since March 2023 until July 1, 2025. She was the Chief Financial Officer of Immunovant, Inc. since November 2019 until July 16, 2021. Most recently, Ms. Connealy served as the Chief Financial Officer, Chief Human Resources Officer and Chief Operating Officer of Kiva Microfunds, a San Francisco based nonprofit organization. From April 2014 to June 2018, Ms. Connealy served as Global Head of Talent at the Bill & Melinda Gates Foundation, focusing on talent management, compensation, benefits and global mobility. From March 2012 to November 2013, she served as Vice President of Business Operations at Salesforce and from March 2002 to April 2010, Ms. Connealy served as a Vice President and Corporate Officer at Genentech, with roles including Chief Financial Officer of Research & Development and Global Head of Procurement. Ms. Connealy currently serves as a member of the board of directors of Health Sciences Acquisitions Corporation 2 (formerly known as Orchestra BioMed, Inc.) Ms. Connealy earned a B.S. in Chemistry from Gannon University and an M.B.A. in Finance from the University of St. Thomas in Houston, Texas.
Positions
- Company NameOrchestra BioMed Holdings, Inc.Stock CodeOBIOPositionIndependent DirectorColleagues
- DPDavid P. HochmanFounder, Chairman of the Board of Directors & CEO
- DRDarren R. ShermanFounder, President, COO & Director
- ALAndrew Lawrence TaylorChief Financial Officer
- WRWilliam Reed LittleExecutive Vice President of Corporate Development & Strategy
- LDLisa DanielsVice President of Human Resources
- ESEric S. FainIndependent Lead Director
- JMJason M. AryehIndependent Director
